Castle Biosciences Inc. (CSTL) Tops Q3 EPS by 50c

Castle Biosciences Inc. (NASDAQ: CSTL) reported Q3 EPS of ($0.02), $0.50 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $83 million versus the consensus estimate of $71.03 million.

For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Bonk, Inc. posts $5.5M revenue in H1 2026, reports $7.88M net loss
• Mobix Labs guides fiscal Q4 revenue up ~100% quarter over quarter